Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorInstituto Nacional de Cancerologia de Mexico

About this trial

Breast cancer is the leading cause of mortality in women worldwide. Latin-American women are diagnosed at younger ages, in advanced stages, and with aggressive molecular subtypes. Lifestyle seems related to these aggressive conditions and worse outcomes. The present study seeks to evaluate the effect of a hybrid multidisciplinary intervention for implementing a healthy lifestyle to modify the personal and internal exposome of young women with breast cancer. This randomized controlled experimental study with two groups:

Group 1: Hybrid multidisciplinary lifestyle education intervention. Group 2: Individualized hybrid multidisciplinary lifestyle interventions. The multidisciplinary lifestyle intervention program includes oncology, nutrition, physiotherapy, and psychology interventions.

Eligibility criteria

Qualifiers

Women diagnosed with stage I-III BC, confirmed by pathology and image at the INCAN

Candidates for multidisciplinary treatment including surgery, chemotherapy, and/or hormonal treatments.

Signed the informed consent form

Have access to a mobile phone or any electronic device with an active internet connection to receive the program information.

Disqualifiers

Patients with inflammatory cancer

Those with cardiomyopathy or ventricular dysfunction (NYHA >II), arrythmia secondary to left ventricular ejection alterations that requires medication, previous myocardial infarction, or angina pectoris in the last six months

Receiving treatment for cardiovascular or cerebrovascular disease, inflammatory bowel disease, malabsorption syndrome, rheumatoid arthritis, lupus, thyroid diseases, or Cushing syndrome

Unable to walk for at least 1 km

Trial design

Treatments tested in this trial

  • Hybrid lifestyle educational multidisciplinary intervention.
  • Hybrid lifestyle personalized multidisciplinary intervention.

Treatment groups

146 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Instituto Nacional de Cancerologia de Mexico

Lead sponsor

Anahuac University

Collaborator

Tecnologico de Monterrey

Collaborator

Instituto Nacional de Rehabilitacion

Collaborator

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Collaborator

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Collaborator